Table 2. Treatment-Emergent Adverse Events Reported in 3 or More Patients.
| Adverse events | Patients, No. (%) (n = 48) |
|---|---|
| Upper respiratory tract infection | 20 (42) |
| Nasopharyngitis | 10 (21) |
| Somnolence | 6 (13) |
| Vomiting | 5 (10) |
| Application site dryness | 4 (8) |
| Application site pain | 4 (8) |
| Decreased appetite | 4 (8) |
| Diarrhea | 4 (8) |
| Gastroenteritis | 4 (8) |
| Pyrexia | 4 (8) |
| Viral infection | 4 (8) |
| Viral upper respiratory tract infection | 4 (8) |
| Contusion | 3 (6) |
| Cough | 3 (6) |
| Ear infection | 3 (6) |
| Fall | 3 (6) |
| Fatigue | 3 (6) |
| Pneumonia | 3 (6) |
| Scratch | 3 (6) |
| Seizure | 3 (6) |